Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive-Reference-Cited by-同舟云学术

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive

Published:2008-02-09 Issue:1 Volume:113 Page:181-187
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Van Calster Ben,Vanden Bempt Isabelle,Drijkoningen Maria,Pochet Nathalie,Cheng Jiqiu,Van Huffel Sabine,Hendrickx Wouter,Decock Julie,Huang Huei-Jean,Leunen Karin,Amant Frederic,Berteloot Patrick,Paridaens Robert,Wildiers Hans,Van Limbergen Erik,Weltens Caroline,Timmerman Dirk,Van Gorp Toon,Smeets Ann,Van den Bogaert Walter,Vergote Ignace,Christiaens Marie-Rose,Neven Patrick

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-9914-7.pdf

Reference51 articles.

1. Esteva FJ, Hortobagyi GN (2004) Prognostic molecular markers in early breast cancer. Breast Cancer Res 6:109–118

2. Akiyama T, Sudo C, Ogawara H et al (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644–1646

3. Slamon DJ, Clark GM, Wong SG et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2 oncogene. Science 235:177–182

4. Slamon DJ, Godolphin W, Jones LA et al (1989) Studies of the HER-2 proto-oncogene in human breast and ovarian cancer. Science 244:707–712

5. Paik S, Hazan R, Fisher ER et al (1990) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol 8:103–112

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of axillary lymph node metastasis with the ultrasound and Magnetic Resonance Imaging features in breast cancer;2024-08-17

2. Insights into the Emerging Therapeutic Targets of Triple-negative Breast Cancer;Current Cancer Drug Targets;2024-02-21

3. Discovery of a proliferation essential gene signature and actin‐like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple‐positive breast cancer;Cancer;2024-02-15

4. Association between postoperative pathological results and non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node-positive breast cancer;World Journal of Surgical Oncology;2024-01-24

5. Predictive biological factors for late survival in patients with HER2-positive breast cancer;Scientific Reports;2023-07-07